Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

Advanced Bladder Cancer Meta-analysis Collaboration.

Lancet. 2003 Jun 7;361(9373):1927-34. Review.

PMID:
12801735
2.

Neoadjuvant chemotherapy for invasive bladder cancer.

Advanced Bladder Cancer Overview Collaboration.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD005246. Review.

PMID:
15846746
3.

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

Eur Urol. 2005 Aug;48(2):202-5; discussion 205-6. Epub 2005 Apr 21.

PMID:
15939524
4.

WITHDRAWN: Neoadjuvant cisplatin for advanced bladder cancer.

Advanced Bladder Cancer Meta-analysis Collaboration.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD001426. doi: 10.1002/14651858.CD001426.pub2. Review.

PMID:
21678333
5.

Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.

Yin M, Joshi M, Meijer RP, Glantz M, Holder S, Harvey HA, Kaag M, Fransen van de Putte EE, Horenblas S, Drabick JJ.

Oncologist. 2016 Jun;21(6):708-15. doi: 10.1634/theoncologist.2015-0440. Epub 2016 Apr 6. Review.

6.

Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials.

Leow JJ, Martin-Doyle W, Rajagopal PS, Patel CG, Anderson EM, Rothman AT, Cote RJ, Urun Y, Chang SL, Choueiri TK, Bellmunt J.

Eur Urol. 2014 Jul;66(1):42-54. doi: 10.1016/j.eururo.2013.08.033. Epub 2013 Aug 28. Review.

PMID:
24018020
7.

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

Eur Urol. 2005 Aug;48(2):189-199; discussion 199-201. Epub 2005 Apr 25.

PMID:
15939530
8.

Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies.

Sherif A, Holmberg L, Rintala E, Mestad O, Nilsson J, Nilsson S, Malmström PU; Nordic Urothelial Cancer Group.

Eur Urol. 2004 Mar;45(3):297-303.

PMID:
15036674
10.

A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer.

Wosnitzer MS, Hruby GW, Murphy AM, Barlow LJ, Cordon-Cardo C, Mansukhani M, Petrylak DP, Benson MC, McKiernan JM.

Cancer. 2012 Jan 15;118(2):358-64. doi: 10.1002/cncr.26278. Epub 2011 Jun 29.

11.

Neoadjuvant cisplatin for advanced bladder cancer.

Advanced Bladder Cancer Overview Collaboration.

Cochrane Database Syst Rev. 2000;(2):CD001426. Review. Update in: Cochrane Database Syst Rev. 2011;(6):CD001426.

PMID:
10796791
12.

The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan.

Matsui Y, Nishiyama H, Watanabe J, Teramukai S, Ono Y, Ohshima S, Fujimoto K, Hirao Y, Fukushima M, Ogawa O.

Int J Clin Oncol. 2005 Apr;10(2):133-8.

PMID:
15864700
13.

Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer.

Matsubara N, Mukai H, Naito Y, Nezu M, Itoh K.

Asia Pac J Clin Oncol. 2013 Dec;9(4):310-7. doi: 10.1111/ajco.12017. Epub 2012 Nov 6.

14.

Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.

Rosenblatt R, Sherif A, Rintala E, Wahlqvist R, Ullén A, Nilsson S, Malmström PU; Nordic Urothelial Cancer Group.

Eur Urol. 2012 Jun;61(6):1229-38. doi: 10.1016/j.eururo.2011.12.010. Epub 2011 Dec 13.

PMID:
22189383
15.

Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis.

Petrelli F, Coinu A, Cabiddu M, Ghilardi M, Vavassori I, Barni S.

Eur Urol. 2014 Feb;65(2):350-7. doi: 10.1016/j.eururo.2013.06.049. Epub 2013 Jul 3. Review.

PMID:
23849998
16.

Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.

Segal R, Winquist E, Lukka H, Chin JL, Brundage M, Markman BR; Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group.

Can J Urol. 2002 Oct;9(5):1625-33.

PMID:
12431323
17.

Adjuvant chemotherapy for invasive bladder cancer (individual patient data).

Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD006018. Review.

PMID:
16625650
18.

Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours.

Sengeløv L, von der Maase H, Lundbeck F, Barlebo H, Colstrup H, Engelholm SA, Krarup T, Madsen EL, Meyhoff HH, Mommsen S, Nielsen OS, Pedersen D, Steven K, Sørensen B.

Acta Oncol. 2002;41(5):447-56.

PMID:
12442921
19.

Neoadjuvant chemotherapy in muscle-invasive bladder cancer: ready for prime time?

Pouessel D, Mongiat-Artus P, Culine S.

Crit Rev Oncol Hematol. 2013 Mar;85(3):288-94. doi: 10.1016/j.critrevonc.2012.09.002. Epub 2012 Sep 27. Review.

PMID:
23022113
20.

A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.

Meeks JJ, Bellmunt J, Bochner BH, Clarke NW, Daneshmand S, Galsky MD, Hahn NM, Lerner SP, Mason M, Powles T, Sternberg CN, Sonpavde G.

Eur Urol. 2012 Sep;62(3):523-33. doi: 10.1016/j.eururo.2012.05.048. Epub 2012 Jun 1. Review.

PMID:
22677572

Supplemental Content

Support Center